Pediatric ophthalmologist Dr. Christin Sylvester reviews current and emerging treatments for Retinopathy of Prematurity or ROP.

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Employ the current Retinopathy of Prematurity (ROP) classification
  • Describe the pathogenesis and stages of ROP
  • Identify treatment options (including emerging treatment) for ROP and be able to counsel families on ROP


Reading Resources:

  1. Chang et al. Arch of opth 2007
  2. Hagadern JI, Achieved vs. Interded...
  3. Darlow B, Prenatal Risk Factors for..
  4. Hiraoka M, Genetic screening of Klint Signaling...

Disclosures:

Dr. Sylvester has no relevant relationships with any entities producing healthcare goods or services.

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.1) continuing education units (CEU) which are equivalent to 1.0 contact hours.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

Release Date: 11/29/2011 | Last Modified On: 4/1/2013 | Expires: 4/1/2014

This course has been expired.